Targeting acidosis to improve immunotherapy in a pancreatic ductal adenocarcinoma model

被引：0
|
作者：
Perassi, B. Victorasso Jardim [1 ]
Abrahams, D. [2 ]
Irrera, P. [1 ]
Whelan, C. [3 ]
Beatty, M. [4 ]
Byrne, S. [4 ]
Longo, D. [5 ]
Gaspar, K. [6 ]
Pilon-Thomas, S. [4 ]
Hashim, A. Ibrahim [1 ]
Bohler, C. [6 ]
Gillies, R. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Canc Physiol, Tampa, FL USA
[2] Univ S Florida, Comparat Med, Tampa, FL 33620 USA
[3] Univ Illinois, Biol Sci, Chicago, IL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Immunol, Tampa, FL USA
[5] CNR, Inst Biostruct & Bioimages, Turin, Italy
[6] Helix BioPharma Corp, Toronto, ON, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
250
引用
收藏
页码：S90 / S91
页数：2
相关论文
共 50 条
  • [1] Delivering a Double Whammy: Targeting Stroma to Improve Immunotherapy Outcomes in Pancreatic Ductal Adenocarcinoma
    Lavania, Shweta
    GASTROENTEROLOGY, 2022, 163 (05) : 1159 - 1161
  • [2] Immunotherapy for pancreatic ductal adenocarcinoma
    Carpenter, Eileen
    Nelson, Sarah
    Bednar, Filip
    Cho, Clifford
    Nathan, Hari
    Sahai, Vaibhav
    di Magliano, Marina Pasca
    Frankel, Timothy L.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 751 - 759
  • [3] Advances in immunotherapy for pancreatic ductal adenocarcinoma
    Miyazawa, Motoki
    Katsuda, Masahiro
    Kawai, Manabu
    Hirono, Seiko
    Okada, Ken-ichi
    Kitahata, Yuji
    Yamaue, Hiroki
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (05) : 419 - 430
  • [4] A rat model of pancreatic ductal adenocarcinoma: Targeting chemical carcinogens
    Rivera, JA
    GraemeCook, F
    Werner, J
    Zgraggen, K
    Rustgi, AK
    Rattner, DW
    Warshaw, AL
    FernandezdelCastillo, C
    SURGERY, 1997, 122 (01) : 82 - 90
  • [5] Targeting mTOR in Pancreatic Ductal Adenocarcinoma
    Iriana, Sentia
    Ahmed, Shahzad
    Gong, Jun
    Annamalai, Alagappan Anand
    Tuli, Richard
    Hendifar, Andrew Eugene
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [6] Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
    Singh, Gurkaranjot
    Kutcher, Drew
    Lally, Rajeshwar
    Rai, Vikrant
    CANCERS, 2024, 16 (11)
  • [7] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [8] Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
    Sahin, I. H.
    Askan, G.
    Hu, Z. I.
    O'Reilly, E. M.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 2950 - 2961
  • [9] Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
    Ruining Gong
    He Ren
    Signal Transduction and Targeted Therapy, 5
  • [10] Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy
    Zhang, Han
    Xu, Wenjin
    Zhu, Haitao
    Chen, Xuelian
    Tsai, Hsiang-i
    JOURNAL OF CANCER, 2024, 15 (07): : 2003 - 2023
12345